Healthcare provider profile · identity verified

Jodi Bangasser, ARNP

Nurse Practitioner · CHARLES CITY, IA · NPI 1023465267

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	518	91
Levothyroxine Sodium	Levothyroxine Sodium	401	68
Furosemide	Furosemide	321	49
Lisinopril	Lisinopril	301	53
Potassium Chloride	Potassium Chloride	273	43
Jardiance	Empagliflozin	223	13
Gabapentin	Gabapentin	195	26
Sertraline Hcl	Sertraline Hcl	191	32
Tramadol Hcl	Tramadol Hcl	189	39
Pantoprazole Sodium	Pantoprazole Sodium	184	39
Metoprolol Succinate	Metoprolol Succinate	182	30
Escitalopram Oxalate	Escitalopram Oxalate	181	27
Quetiapine Fumarate	Quetiapine Fumarate	176	23
Eliquis	Apixaban	172	23
Amlodipine Besylate	Amlodipine Besylate	165	37
Metformin Hcl	Metformin Hcl	152	23
Metoprolol Tartrate	Metoprolol Tartrate	138	27
Omeprazole	Omeprazole	136	30
Famotidine	Famotidine	134	19
Trazodone Hcl	Trazodone Hcl	126	24
Warfarin Sodium	Warfarin Sodium	125	suppressed
Donepezil Hcl	Donepezil Hcl	124	16
Xarelto	Rivaroxaban	120	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	118	16
Clopidogrel	Clopidogrel Bisulfate	89	14
Buspirone Hcl	Buspirone Hcl	88	16
Diclofenac Sodium	Diclofenac Sodium	84	21
Ropinirole Hcl	Ropinirole Hcl	82	suppressed
Duloxetine Hcl	Duloxetine Hcl	78	13
Allopurinol	Allopurinol	75	11
Metformin Hcl Er	Metformin Hcl	70	13
Simvastatin	Simvastatin	70	13
Baclofen	Baclofen	66	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	64	suppressed
Losartan Potassium	Losartan Potassium	64	17
Pregabalin	Pregabalin	63	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	57	15
Hydrochlorothiazide	Hydrochlorothiazide	56	16
Januvia	Sitagliptin Phosphate	56	suppressed
Bumetanide	Bumetanide	53	suppressed
Meloxicam	Meloxicam	53	suppressed
Olanzapine	Olanzapine	53	suppressed
Montelukast Sodium	Montelukast Sodium	52	12
Carvedilol	Carvedilol	51	suppressed
Myrbetriq	Mirabegron	51	suppressed
Trulicity	Dulaglutide	50	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	11
Finasteride	Finasteride	47	suppressed
Metolazone	Metolazone	46	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	45	17
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Alendronate Sodium	Alendronate Sodium	44	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Risperidone	Risperidone	43	suppressed
Lorazepam	Lorazepam	42	22
Fenofibrate	Fenofibrate Nanocrystallized	41	suppressed
Spironolactone	Spironolactone	40	suppressed
Midodrine Hcl	Midodrine Hcl	39	suppressed
Prednisone	Prednisone	39	20
Cephalexin	Cephalexin	38	23
Amiodarone Hcl	Amiodarone Hcl	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	35	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Lamotrigine	Lamotrigine	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	26
Ondansetron Hcl	Ondansetron Hcl	31	14
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Insulin Lispro	Insulin Lispro	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Tresiba Flextouch U-200	Insulin Degludec	29	suppressed
Vraylar	Cariprazine Hcl	29	suppressed
Gemtesa	Vibegron	28	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	28	16
Ketoconazole	Ketoconazole	28	15
Nystatin	Nystatin	28	12
Memantine Hcl	Memantine Hcl	27	suppressed
Rexulti	Brexpiprazole	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Ozempic	Semaglutide	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Bupropion Hcl	Bupropion Hcl	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Invokana	Canagliflozin	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Cholestyramine	Cholestyramine (With Sugar)	22	suppressed
Lactulose	Lactulose	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Benztropine Mesylate	Benztropine Mesylate	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	suppressed
Anastrozole	Anastrozole	18	suppressed
Azithromycin	Azithromycin	18	17
Doxycycline Hyclate	Doxycycline Hyclate	18	12
Lokelma	Sodium Zirconium Cyclosilicate	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Topiramate	Topiramate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Lumigan	Bimatoprost	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Torsemide	Torsemide	15	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Imipramine Hcl	Imipramine Hcl	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Levofloxacin	Levofloxacin	14	12
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Trimethoprim	Trimethoprim	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Dofetilide	Dofetilide	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Admelog	Insulin Lispro	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Ethosuximide	Ethosuximide	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Nystop	Nystatin	12	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	12	11
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Primidone	Primidone	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error